// App-Quantinova.ai

3704 : TRISENOX disrupts MDM2-DAXX-HAUSP interaction and increased promyelocytes formation in murine model of APL

Researchers

Presenter

  • Sanjay Kumar

Principal Investigators

  • Paul Tchounwou

Medical Centers

  • Jackson State University, Flowood, MS.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute promyelocytic leukemia

  • Solid malignancies

Biomarkers

  • p53

  • Translocator protein

Drug/Treatment

  • Arsenic trioxide

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A